Given the success of the
Research Advances in Gestational Diabetes Mellitus, Neonatal Diabetes Mellitus, and Metabolic Disorders and the new advances in the field, we are pleased to announce the launch of Volume II.
Gestational diabetes mellitus (GDM) is a hyperglycemic condition most women suffer during pregnancy. There are several causes and complications associated with GDM, and most remain unclear or unknown. As this condition affects the pregnancy outcomes at different stages, it could be dangerous for both mother and the coming baby. Pregnancy complications may include miscarriage or other abnormalities of the fetus or newborn. It may also include neonatal diabetes, however, this is not yet clear. Neonatal diabetes mellitus (NDM) is considered a type of diabetes, which generally occurs during the first six months after birth, and could develop into transient neonatal diabetes mellitus (TNDM) or permanent neonatal diabetes mellitus (PNDM). TNDM is diagnosed within the first 30 days (normally the first 6 days) from birth, but could affect the baby for the first three months of life and may come back in adult age, while permanent neonatal diabetes affects the patient for longer. Neonatal diabetes insurgency is determined by multiple factors including genetics: to date, more than 20 genes have been associated with permanent neonatal diabetes mellitus. These may also associate with Metabolic syndrome (Mts), a medical term used to describe a combination of diabetes, high blood pressure (hypertension), and obesity. Patients affected by these conditions have a greater risk of getting coronary heart disease, stroke, and other disorders that affect the blood vessels. A relationship has been established between maternal Mts, GDM, and pregnancy outcomes.
This article collection welcomes the submission of original research articles, short communications, special reports, meta-analysis, and review articles especially focusing on Gestational diabetes, Neonatal diabetes, and metabolic syndrome, or other related metabolic disorders.
Articles relevant to these topics will be considered for peer review and publication.
Given the success of the
Research Advances in Gestational Diabetes Mellitus, Neonatal Diabetes Mellitus, and Metabolic Disorders and the new advances in the field, we are pleased to announce the launch of Volume II.
Gestational diabetes mellitus (GDM) is a hyperglycemic condition most women suffer during pregnancy. There are several causes and complications associated with GDM, and most remain unclear or unknown. As this condition affects the pregnancy outcomes at different stages, it could be dangerous for both mother and the coming baby. Pregnancy complications may include miscarriage or other abnormalities of the fetus or newborn. It may also include neonatal diabetes, however, this is not yet clear. Neonatal diabetes mellitus (NDM) is considered a type of diabetes, which generally occurs during the first six months after birth, and could develop into transient neonatal diabetes mellitus (TNDM) or permanent neonatal diabetes mellitus (PNDM). TNDM is diagnosed within the first 30 days (normally the first 6 days) from birth, but could affect the baby for the first three months of life and may come back in adult age, while permanent neonatal diabetes affects the patient for longer. Neonatal diabetes insurgency is determined by multiple factors including genetics: to date, more than 20 genes have been associated with permanent neonatal diabetes mellitus. These may also associate with Metabolic syndrome (Mts), a medical term used to describe a combination of diabetes, high blood pressure (hypertension), and obesity. Patients affected by these conditions have a greater risk of getting coronary heart disease, stroke, and other disorders that affect the blood vessels. A relationship has been established between maternal Mts, GDM, and pregnancy outcomes.
This article collection welcomes the submission of original research articles, short communications, special reports, meta-analysis, and review articles especially focusing on Gestational diabetes, Neonatal diabetes, and metabolic syndrome, or other related metabolic disorders.
Articles relevant to these topics will be considered for peer review and publication.